Imaging Technology

JANUARY 12, 2024

a therapeutic oncology company, announced that the Centers for Medicare and Medicaid Services (CMS) has established a national payment rate for RefleXion’s SCINTIX biology-guided radiotherapy using CMS’ New Technology (NT) Ambulatory Payment Classification (APC) pathway. 1, 2024, to describe SCINTIX therapy.

Radiopharmaceuticals 105

Radiopharmaceuticals Radiation Medicare Clinic 105

Imaging Technology

JULY 20, 2023

He previously served on the ASTRO Board as head of the Government Relations Council, helping lead ASTRO’s work with Congress and other policymakers on prior authorization and Medicare payment reform.

Radiation Oncology 98

Radiation Oncology Radiation Government Community Practice 98

AuntMinnie

JANUARY 19, 2024

more than 6 million Americans have Alzheimer's disease, a debilitating and far-reaching disease that accounts for 60% to 80% of dementia cases, and by 2050, this number is projected to rise to nearly 13 million, according to Alzheimer’s Disease International. The disease affects memory, thinking, and behavior. In the U.S.,

Disease 130

Disease Imaging Medicare PET Scan 130

AuntMinnie

OCTOBER 2, 2024

Ultrasound model predicts liver disease progression. Scientific Paper of the Year Advanced Practice Provider Procedures Commonly Performed in Interventional Radiology: Medicare Volume Trends From 2010 to 2021. Commercially Available Chest Radiograph AI Tools for Detecting Airspace Disease, Pneumothorax, and Pleural Effusion.

Digital Imaging and Communications in Medicine 360

Digital Imaging and Communications in Medicine X-ray MRI Hospital 360

Imaging Technology

MAY 23, 2023

The new ASTRO survey illustrates how staffing issues exacerbate the pressures that radiation oncology clinics face due to ongoing and excessive cuts to Medicare reimbursements, burdensome prior authorization requirements, and rising costs and inflation. in Medicare payment policies. Mike Kelly (R-Penn.), Ami Bera, MD (D-Calif.)

Radiation Oncology 96

Radiation Oncology Radiation Clinic Medicare 96

AuntMinnie

JANUARY 8, 2025

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimers Association have released new appropriate use criteria for brain PET imaging of amyloid and tau pathology related to cognitive impairment and Alzheimers disease. Since then, the U.S. There are three PET radiotracers labeled with F-18 approved by the U.S.

Nuclear Medicine 290

Nuclear Medicine Imaging Radiopharmaceuticals Medicare 290

Imaging Technology

JANUARY 14, 2025

8, 2025 The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimers Association have released updated appropriate use criteria (AUC) for amyloid and tau PET imaging in patients with mild cognitive impairment, Alzheimers disease and other dementias. tim.hodson Tue, 01/14/2025 - 16:48 Jan.8, Since then, the U.S.

Nuclear Medicine 52

Nuclear Medicine Imaging Patient Care PET Scan 52